A rival CEO's confrontational social media post underscored the high stakes in the race to develop and deploy cancer ...

While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, ...

The initial results suggest that Exact’s test could be an alternative to others on the market, but the findings come from a ...

Positive results of a colon cancer study conducted by Exact Sciences prompt the CEO of competitor Guardant Health to publicly ...

Exact’s test could compete with Guardant Health’s Shield blood test, which received approval from the Food and Drug Administration in July.

He revealed: "This one ingredient could decrease your risk of colon cancer. I'm a board-certified gastroenterologist. We have ...

Blood in your bowels could be a sign of several potentially serious health conditions, and understanding the cause is crucial ...

Symptoms of colorectal cancer, also commonly known as colon cancer, may include changes in bowel habits, blood in stool, ...

Over the weekend, during the leadup to Exact Sciences announcing data from a blood-based colon cancer test, Guardant Health co-CEO AmirAli Talasaz challenged Exact’s CEO, Kevin Conroy ...

Totò Schillaci, who passed away today, September 18, had been suffering from colon cancer for some time. His condition had ...

Totò Schillaci, who passed away today, September 18, had been suffering from colon cancer for some time. His condition had ...

Exact Sciences released data from a study of its blood-based colorectal cancer screening test that showed sensitivities of 88.3% for colorectal cancer and 31.2% for advanced precancerous lesions.